Neurology, ophthalmology, orl
Zeile 19: | Zeile 19: | ||
− | + | ||
{{tp|p=32278470|t=ä. Upper airway symptoms in coronavirus disease 2019 (COVID-19) |pdf=|usr=}} | {{tp|p=32278470|t=ä. Upper airway symptoms in coronavirus disease 2019 (COVID-19) |pdf=|usr=}} | ||
{{tp|p=32276732|t=ä. Hearing loss and COVID-19: A note |pdf=|usr=}} | {{tp|p=32276732|t=ä. Hearing loss and COVID-19: A note |pdf=|usr=}} | ||
Zeile 38: | Zeile 38: | ||
{{tp|p=32322822|t=ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC |pdf=|usr=}} | {{tp|p=32322822|t=ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC |pdf=|usr=}} | ||
{{tp|p=32283246|t=ä. Treating the Mental Health Effects of COVID-19: The Need for At-Home Neurotherapeutics Is Now |pdf=|usr=}} | {{tp|p=32283246|t=ä. Treating the Mental Health Effects of COVID-19: The Need for At-Home Neurotherapeutics Is Now |pdf=|usr=}} | ||
− | |||
− | |||
− | + | ||
{{tp|p=32328364|t=ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy |pdf=|usr=}} | {{tp|p=32328364|t=ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy |pdf=|usr=}} | ||
Zeile 53: | Zeile 51: | ||
{{tp|p=32362868|t=2020. Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic |pdf=|usr=}} | {{tp|p=32362868|t=2020. Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic |pdf=|usr=}} | ||
− | + | ||
{{tp|p=32328758|t=ä. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid |pdf=|usr=}} | {{tp|p=32328758|t=ä. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid |pdf=|usr=}} | ||
{{tp|p=32363146|t=2020. COVID-19 Presenting with Seizures |pdf=|usr=}} | {{tp|p=32363146|t=2020. COVID-19 Presenting with Seizures |pdf=|usr=}} | ||
− | + | ||
{{tp|p=32314322|t=ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights |pdf=|usr=}} | {{tp|p=32314322|t=ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights |pdf=|usr=}} | ||
− | + | ||
− | + | ||
{{tp|p=32307298|t=ä. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis |pdf=|usr=}} | {{tp|p=32307298|t=ä. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis |pdf=|usr=}} | ||
− | + | ||
{{tp|p=32334847|t=ä. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): interest of telemedicine during the pandemic context |pdf=|usr=}} | {{tp|p=32334847|t=ä. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): interest of telemedicine during the pandemic context |pdf=|usr=}} | ||
{{tp|p=32165057|t=2020. Le nouveau Coronavirus Covid-19: quels risques ophtalmiques?|pdf=|usr=}} | {{tp|p=32165057|t=2020. Le nouveau Coronavirus Covid-19: quels risques ophtalmiques?|pdf=|usr=}} | ||
Zeile 86: | Zeile 83: | ||
{{tp|p=32322398|t=2020. COVID-19 and intracerebral haemorrhage: causative or coincidental?|pdf=|usr=}} | {{tp|p=32322398|t=2020. COVID-19 and intracerebral haemorrhage: causative or coincidental?|pdf=|usr=}} | ||
{{tp|p=32175797|t=2020. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals |pdf=|usr=}} | {{tp|p=32175797|t=2020. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals |pdf=|usr=}} | ||
− | + | ||
− | + | ||
{{tp|p=32359841|t=ä. A Rashomon Moment? Ocular Involvement and COVID-19 |pdf=|usr=}} | {{tp|p=32359841|t=ä. A Rashomon Moment? Ocular Involvement and COVID-19 |pdf=|usr=}} | ||
Zeile 116: | Zeile 112: | ||
− | + | ||
Zeile 123: | Zeile 119: | ||
{{tp|p=32352575|t=2020. Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients" |pdf=|usr=}} | {{tp|p=32352575|t=2020. Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients" |pdf=|usr=}} | ||
− | + | ||
{{tp|p=32246782|t=2020. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2 |pdf=|usr=}} | {{tp|p=32246782|t=2020. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2 |pdf=|usr=}} | ||
− | |||
− | |||
− | |||
Zeile 150: | Zeile 143: | ||
− | |||
− | |||
Zeile 165: | Zeile 156: | ||
− | + | ||
Version vom 11. Juni 2020, 12:27 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
- Cerebral embolism
- Smell and taste disorder
- Brain infection Neurotropism
- Guillain-Barre Syndrome
- Autoimmune Neuropathies
- Neurology Reviews and Multitopic
32310553 2020. Ophthalmic Manifestations Of Coronavirus (COVID-19)
32348111 ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? |
32278470 ä. Upper airway symptoms in coronavirus disease 2019 (COVID-19)
32276732 ä. Hearing loss and COVID-19: A note
32327217 ä. COVID-19 and hearing difficulties
32345855 2020. Coronavirus Disease 2019 Pandemic Acute Respiratory Distress Syndrome Survivors: Pain After the Storm?
32265202 2020. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease
32298803 ä. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms?
32322822 ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC
32283246 ä. Treating the Mental Health Effects of COVID-19: The Need for At-Home Neurotherapeutics Is Now
32328364 ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy
32283980 2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms
32370982 ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review
32362868 2020. Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic
32328758 ä. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid
32363146 2020. COVID-19 Presenting with Seizures
32314322 ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights
32307298 ä. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis
32334847 ä. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): interest of telemedicine during the pandemic context
32165057 2020. Le nouveau Coronavirus Covid-19: quels risques ophtalmiques?
32232433 2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China
32361098 2020. Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?
32322398 2020. COVID-19 and intracerebral haemorrhage: causative or coincidental?
32175797 2020. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals
32359841 ä. A Rashomon Moment? Ocular Involvement and COVID-19
32246403 ä. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion
32344366 2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report
32378854 2020. Covid-19 med nedsatt lukte- og smakssans som eneste symptom
32359765 ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System
32374367 ä. Delirium: a missing piece in the COVID-19 pandemic puzzle
32336042 2020. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19
32086236 2020. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear
32379592 2020. Emerging evidence for neuropsycho-consequences of COVID-19
32333819 2020. COVID-19: what if the brain had a role in causing the deaths?
32301553 2020. Lack of dyspnea in patients with Covid-19: another neurological conundrum? |
32246784 ä. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID?19 |
32352575 2020. Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients"
32246782 2020. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2
32267483 2020. Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19
32291797 2020. SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration
32380269 ä. The COVID-19 pandemic: consideration for brain infection
32369434 2020. Acute Parotitis: A Possible Precocious Clinical Manifestation of SARS-CoV-2 Infection?
32228363 2020. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features
32338254 2020. Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss
32319971 2020. Anosmia as a prominent symptom of COVID-19 infection
32240279 2020. Isolated sudden onset anosmia in COVID-19 infection A novel syndrome?
32277751 2020. Presentation of new onset anosmia during the COVID-19 pandemic
32377594 2020. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2
32389704 ä. Pain: A potential new label of COVID-19
32387342 ä. Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19
32409210 ä. Coexistence of COVID-19 and acute ischemic stroke report of four cases
32355557 ä. Ophthalmic manifestations of novel coronaviruses: precautionary measures and diagnostic possibilities
32388138 2020. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection |
32380269 2020. The COVID-19 Pandemic: Consideration for Brain Infection
32342265 ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome